Navigation Links
Dr. Paul Karila Appointed Head of Discovery Services at Cellectricon AB
Date:6/7/2012

GOTHENBURG, Sweden, June 7, 2012 /PRNewswire/ --

Cellectricon is pleased to announce the appointment of Paul Karila as the company's Head of Discovery Services. Dr. Karila brings a solid and highly impressive neuroscience discovery track record to Cellectricon, important for the company's expansion in bringing state-of-the-art discovery services to market. Paul has extensive experience of the drug discovery industry and has held several management positions at AstraZeneca.

The Company's Discovery Services will be based on the proprietary Cellaxess® Elektra platform for automated cellular electric field manipulation enabling novel screening applications in the CNS and Cardiovascular therapeutic fields.

Cellectricon's CEO David Burns said: "Cellectricon is delighted with the appointment of Dr. Karila. We are looking forward to working with Paul's experience and direction to broaden our cell-based CNS and Cardiovascular Discovery Services using the Company's strong IP and technology position to accelerate discovery through collaborations with our pharmaceutical partners".

Dr. Karila added:  "Cellectricon has a strong reputation in the discovery industry with equally strong customer validation and well-earned reputation for providing groundbreaking products and services to the pharmaceutical and life science research markets. Working with the strong scientific team, I will focus on further developing and providing outstanding cell-based discovery services to our customers to accelerate their drug discovery and biological research. "

Cellectricon is a leading provider of advanced cell-based screening technologies and services to accelerate drug discovery and cell-based assay research. Our proprietary technologies include leading systems for high resolution ion-channel screening and cell engineering. Developed in close collaboration with leaders in the pharmaceutical industry and esteemed research labs, the Cellaxess® Technology enables scalable field stimulation, compound delivery and transfection for genomic screening of primary cells, neurones and stem cells. The Dynaflow® Technology advances ion channel research and discovery applications.

http://www.cellectricon.com


'/>"/>
SOURCE Cellectricon AB
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Israel Makov Appointed Chairman of Sun Pharma Board
2. New Executive Vice President Commercial Appointed
3. Herb Baer Appointed President of Polar USA
4. Anthony McKeever Appointed as Chief Executive of MedeAnalytics International
5. Samuel J. Sears, Jr. Appointed to BioDelivery Sciences Board of Directors
6. ActiveCare, Inc. Announces a Newly Appointed CEO
7. Nader Naeymi-Rad Appointed CEO of Campbell Alliance
8. David J. Illingworth Appointed to Board of Directors for Varian Medical Systems
9. Nils Bergenhem, PhD - Newly Appointed President and Chief Scientific Officer of Egenix, Inc.
10. New Senior Executives Appointed at Sanofi:
11. Lilly Quality Leader Walsh Appointed to Companys Executive Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... Sept. 5, 2017  Just 18 months after its ... pleased to announce the appointment of three new senior ... , Dominic Jones-Phillips and James Wright ... Tammy Wynne ... market access writers. She has over ten years, experience ...
(Date:8/31/2017)... , Aug. 31, 2017 PM360,s ... must-read guide to the latest innovations happening across the ... industry publication to focus on providing a comprehensive look ... the issue covers the most innovative companies, startups, divisions, ... "Everyone in this industry ...
(Date:8/25/2017)... 2017  Innovation Zed ( www.innovationzed.com ), an Irish medtech company, today ... South Yorkshire and Bassetlaw, England . ... diabetes patients as part of a national NHS Test Bed programme exploring ... Innovation Zed ... InsulCheck Connect, a snap-on accessory for disposable insulin pen users, ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy ... industry-leading compliance software, The Guard®, has helped another long-time client pass their Department ... and properly satisfy the law. , Thanks to the help of the Compliancy ...
(Date:9/20/2017)... ... 2017 , ... The Honey Pot Company is thrilled to ... to ignite conversation via social media and word-of-mouth regarding vaginal health, human rights ... “Humans with Vaginas” month, releasing a video celebrating the power of strong voices ...
(Date:9/20/2017)... ... 2017 , ... Medicare doesn’t have the authority to negotiate ... their prescription drugs, according to a new comparison of drug plans by ... there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare policy ...
(Date:9/20/2017)... , ... September 20, 2017 , ... “The Trials I ... and tribulations as he emotionally pens his aspirations and goals to better one’s life ... published author, Jimmy Green, while searching in all the wrong places, found a love ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. That’s ... and rolled up their sleeves to help with relief efforts. The team picked up ... of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms have ...
Breaking Medicine News(10 mins):